(MKL) Markel - Overview
Stock: Insurance, Reinsurance, Investments, Manufacturing, Services
EPS (Earnings per Share)
Revenue
| Risk 5d forecast | |
|---|---|
| Volatility | 20.6% |
| Relative Tail Risk | -9.76% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.01 |
| Alpha | 2.17 |
| Character TTM | |
|---|---|
| Beta | 0.584 |
| Beta Downside | 0.567 |
| Drawdowns 3y | |
|---|---|
| Max DD | 18.51% |
| CAGR/Max DD | 0.86 |
Description: MKL Markel December 17, 2025
Markel Group Inc. (NYSE:MKL) operates a diversified insurance and reinsurance platform that underwrites a broad spectrum of property-and-casualty products-including general liability, workers’ compensation, marine/energy, and catastrophe-exposed property lines-while also providing credit, surety, and collateral protection coverage. The firm extends its risk-transfer expertise into specialty treaty reinsurance (e.g., aviation, space, political violence) and supplements underwriting with a sizable investment arm that manages insurance-linked securities such as catastrophe bonds and industry-loss warranties.
Key quantitative signals as of the most recent FY2024 filing show a combined ratio of 95.2% (indicating underwriting profitability), a return on equity (ROE) of 12.8%-above the property-and-casualty industry median of roughly 9%-and an investment portfolio yielding 5.4% in a rising-rate environment, which helps offset underwriting volatility. The primary macro drivers for Markel remain U.S. hurricane and wildfire activity (historical loss frequency ≈ 1.3 events / year) and the broader reinsurance capacity cycle, where excess capacity can compress pricing but also create opportunities for selective underwriting.
For a data-driven deep-dive on how these dynamics translate into valuation metrics, a quick look at ValueRay’s analyst toolkit can be a useful next step.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.42b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.74 > 1.0 |
| NWC/Revenue: error (cannot be calculated; needs Current Assets/Liabilities and Revenue current+prev) |
| CFO/TA 0.04 > 3% & CFO 2.59b > Net Income 2.42b |
| Net Debt (4.28b) to EBITDA (3.09b): 1.39 < 3 |
| Current Ratio: error (cannot be calculated; needs correct Total Current Assets and Liabilities) |
| Outstanding Shares: last quarter (12.7m) vs 12m ago -1.52% < -2% |
| Gross Margin: 62.87% > 18% (prev 0.55%; Δ 6231 % > 0.5%) |
| Asset Turnover: 24.00% > 50% (prev 27.06%; Δ -3.06% > 0%) |
| Interest Coverage Ratio: 20.35 > 6 (EBITDA TTM 3.09b / Interest Expense TTM 105.9m) |
What is the price of MKL shares?
Over the past week, the price has changed by +3.01%, over one month by -1.44%, over three months by +4.62% and over the past year by +2.05%.
Is MKL a buy, sell or hold?
- StrongBuy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MKL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2039.3 | -3% |
| Analysts Target Price | 2039.3 | -3% |
| ValueRay Target Price | 2355.7 | 12.1% |
MKL Fundamental Data Overview February 07, 2026
P/E Forward = 14.2857
P/S = 1.6352
P/B = 1.4358
P/EG = 4.4306
Revenue TTM = 15.51b USD
EBIT TTM = 2.15b USD
EBITDA TTM = 3.09b USD
Long Term Debt = 4.28b USD (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = 4.28b USD (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 4.28b USD (using Total Debt 4.28b, CCE unavailable)
Enterprise Value = 30.79b USD (26.51b + Debt 4.28b - (null CCE))
Interest Coverage Ratio = 20.35 (Ebit TTM 2.15b / Interest Expense TTM 105.9m)
EV/FCF = 12.96x (Enterprise Value 30.79b / FCF TTM 2.38b)
FCF Yield = 7.71% (FCF TTM 2.38b / Enterprise Value 30.79b)
FCF Margin = 15.31% (FCF TTM 2.38b / Revenue TTM 15.51b)
Net Margin = 15.58% (Net Income TTM 2.42b / Revenue TTM 15.51b)
Gross Margin = 62.87% ((Revenue TTM 15.51b - Cost of Revenue TTM 5.76b) / Revenue TTM)
Gross Margin QoQ = none% (prev 54.97%)
Tobins Q-Ratio = 0.46 (Enterprise Value 30.79b / Total Assets 67.39b)
Interest Expense / Debt = -1.17% (Interest Expense -50.0m / Debt 4.28b)
Taxrate = 21.0% (US default 21%)
NOPAT = 1.70b (EBIT 2.15b * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets 26.15b / Total Current Liabilities none)
Debt / Equity = 0.24 (Debt 4.28b / totalStockholderEquity, two quarters ago 18.04b)
Debt / EBITDA = 1.39 (Net Debt 4.28b / EBITDA 3.09b)
Debt / FCF = 1.80 (Net Debt 4.28b / FCF TTM 2.38b)
Total Stockholder Equity = 17.36b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.74% (Net Income 2.42b / Total Assets 67.39b)
RoE = 13.92% (Net Income TTM 2.42b / Total Stockholder Equity 17.36b)
RoCE = 9.96% (EBIT 2.15b / Capital Employed (Equity 17.36b + L.T.Debt 4.28b))
RoIC = 7.86% (NOPAT 1.70b / Invested Capital 21.65b)
WACC = 6.82% (E(26.51b)/V(30.79b) * Re(8.07%) + D(4.28b)/V(30.79b) * Rd(-1.17%) * (1-Tc(0.21)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.11%
[DCF Debug] Terminal Value 83.02% ; FCFF base≈2.48b ; Y1≈2.57b ; Y5≈2.91b
Fair Price DCF = 4903 (EV 66.12b - Net Debt 4.28b = Equity 61.83b / Shares 12.6m; r=6.82% [WACC]; 5y FCF grow 3.55% → 2.90% )
EPS Correlation: 53.14 | EPS CAGR: 37.48% | SUE: 1.52 | # QB: 2
Revenue Correlation: 53.38 | Revenue CAGR: 7.26% | SUE: -1.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=27.41 | Chg30d=+1.730 | Revisions Net=-2 | Analysts=1
EPS current Year (2026-12-31): EPS=118.95 | Chg30d=+5.769 | Revisions Net=-2 | Growth EPS=+6.1% | Growth Revenue=+3.2%
EPS next Year (2027-12-31): EPS=122.84 | Chg30d=-2.420 | Revisions Net=-2 | Growth EPS=+3.3% | Growth Revenue=+2.7%